HCM
NVO

Hollencrest Capital Management’s Novo Nordisk NVO Stock Holding History

Hollencrest Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24K Hold
500
– – ﹤0.01% 699
2026
Q1 		$18.4K Buy
+500
New +$23.7K ﹤0.01% 739
2024
Q4 		– Sell
-2,000
Closed -$238K – 1203
2024
Q3 		$238K Buy
2,000
+1,900
+1,900% +$253K 0.01% 275
2024
Q2 		$14.3K Buy
+100
New +$13.3K ﹤0.01% 708

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Hollencrest Capital Management's NVO Position: Q2 2026 in Review

Hollencrest Capital Management held its Novo Nordisk (NVO) position steady in Q2 2026 at 1,841 shares worth $88.3K. The position accounts for 0.01% of the portfolio, ranked #471.

Hollencrest Capital Management first reported a position in NVO in Q4 2022 and has held it in 15 quarters since. The position peaked at $900K in Q1 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Hollencrest Capital Management held 1,841 shares of Novo Nordisk worth $88.3K as of Q2 2026.
  • Hollencrest Capital Management left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up 0.01% of Hollencrest Capital Management's portfolio in Q2 2026, its #471 holding.
  • Hollencrest Capital Management first reported a position in Novo Nordisk in Q4 2022 and has held it in 15 quarters since.
  • Hollencrest Capital Management's Novo Nordisk position peaked at $900K in Q1 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Hollencrest Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.